Lexeo Therapeutics, Inc. Common Stock (LXEO) — Long-term Investment Intensity
Lexeo Therapeutics, Inc. Common Stock (LXEO) has a Long-term Investment Intensity of 15.1% as of March 2026. Long-term investments of $37.90 Million represent 15.1% of total assets of $250.36 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Lexeo Therapeutics, Inc. Common Stock liquidity resilience to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Lexeo Therapeutics, Inc. Common Stock Long-term Investment Intensity (2024–2025)
This chart shows how Lexeo Therapeutics, Inc. Common Stock's Long-term Investment Intensity has evolved across 2 annual periods from 2024 to 2025. As of March 2026, the intensity stands at 15.1%, reflecting long-term investments of $37.90 Million against total assets of $250.36 Million USD. For the complete balance sheet picture, see LXEO current and non-current assets.
Annual Long-term Investment Intensity for Lexeo Therapeutics, Inc. Common Stock (2024–2025)
The table below presents the year-by-year Long-term Investment Intensity for Lexeo Therapeutics, Inc. Common Stock from 2024 to 2025, covering 2 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read Lexeo Therapeutics, Inc. Common Stock debt and liabilities for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 25.4% | $68.19 Million | $268.69 Million | ▲ +20.6 pp |
| 2024 | 4.8% | $7.01 Million | $146.94 Million | — |